Forward PE Ratio: N/A
The forward PE ratio is N/A as of Thursday, July 9, 2026.
Forward PE Ratio (N/A) = Close Price ($21.23) / Consensus Forward EPS ($-1.69)
SI Forward PE Ratio Metrics
FORWARD PE RATIO
N/A
SI Competitors' Forward PE Ratio
Shoulder Innovations, Inc.
Market Cap
$440.27M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Shoulder Innovations, Inc. (SI) | $440.27M | N/A |
| National Research Corporation (NRC)vs › | $489.27M | 24.85 |
| 23andMe Holding Co. (ME)vs › | $15.31M | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.66B | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.38B | 8.31 |
| TransMedics Group, Inc. (TMDX)vs › | $2.49B | 36.64 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.91B | N/A |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.04B | 31.40 |
| Oscar Health, Inc. (OSCR)vs › | $8.09B | 29.55 |
| Henry Schein, Inc. (HSIC)vs › | $9.55B | 15.56 |
Trailing vs Forward
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus next-FY EPS
Forward P/E by Fiscal Year
View All Analyst EstimatesAt today's $21.23 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-1.69 | $-1.72 – $-1.66 | 2 | n/m |
| 2027-12-31 | $-1.36 | $-1.39 – $-1.33 | 2 | n/m |
| 2028-12-31 | $-1.10 | $-1.45 – $-0.89 | 4 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
Forward PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Related Metrics
About Shoulder Innovations, Inc.
Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Robert Joseph Ball